HireQuest (HQI) Q2 2026 earnings review
A Clean Breakout: Growth Reverses to Positive as Margins Explode
HireQuest turned a massive corner in Q2, posting its first reported year-over-year revenue growth (+6.0%) in over a year. The underlying performance is even stronger: adjusting for the MRI Network divestiture, revenue surged 16.6% and system-wide sales grew 6.9%. The franchise model's operational leverage was on full display as a 32% drop in SG&A expenses propelled Adjusted EBITDA up 42% and Net Income up an impressive 154%. While working capital is eating up cash as receivables expand, the multi-year staffing slump appears to be firmly in the rearview mirror.
🐂 Bull Case
Stripping away the noise of the MRI Network divestiture, core system-wide sales shifted from 'nearly flat' in Q1 to a robust 6.9% growth in Q2. The core franchise engine is firing again.
SG&A expenses plummeted by nearly $2 million (-31.9% YoY). Generating $8.1M in revenue on just $4.0M in SG&A proves the deep structural profitability of HireQuest's franchise model.
🐻 Bear Case
Cash on hand has dwindled from $3.9M at year-end to just $1.6M today, directly caused by Accounts Receivable ballooning to $48.9M. Growth is expensive to fund.
In Q1, management loudly announced a $105M unsolicited bid for a TrueBlue segment. Q2 materials are entirely silent on the matter, suggesting the transformative deal may have failed.
⚖️ Verdict: 🟢
Bullish. Management promised 'green shoots' in Q1, and Q2 delivered them. The Reversing trend in top-line growth combined with extreme margin leverage makes this a standout quarter.
Key Themes
Operational Leverage Unlocked
SG&A expenses collapsed from $5.9M in 25Q2 to $4.0M in 26Q2. This 32% reduction is driving immense bottom-line leverage. When you strip out prior-year divestiture noise, the core business generated $1.3M more in Adjusted EBITDA (+42% YoY) on only $461K of additional reported revenue. This is a dramatic acceleration in profitability.
Pro Forma Sales Acceleration
The headline numbers hide the real trajectory. Because HireQuest divested the permanent placement assets of MRI Network on January 1, reported system-wide sales declined 6.4% to $117.8M. However, on a pro forma basis (apples-to-apples), system-wide sales are Accelerating—growing 6.9% in Q2 compared to roughly 0% in Q1.
Macro Turnaround: Job Market Trough Over
After a grueling two-year 'wait-and-see' environment characterized by manufacturing contraction and hiring freezes, management explicitly called out a 'stabilizing job market and recovering demand environment.' The macro headwinds are Reversing into tailwinds.
Workers' Compensation De-risking
A historically volatile line item has been neutralized. Workers' compensation expense was practically non-existent at $39K for the quarter, down from $127K a year ago. This continuous improvement reflects better risk management and mix shift, permanently expanding structural margins.
Digital Staffing Innovation Integration
To achieve a 32% reduction in SG&A while simultaneously growing pro forma revenues by 16.6%, the company is heavily leaning on its digital infrastructure. The ongoing integration of acquired technology assets (like Recruit Media) allows the franchisor to support higher system-wide sales volumes without linearly scaling corporate headcount. Technology is acting as the silent margin driver.
Working Capital Squeeze
While net income looks great, cash generation tells a different story. Cash dropped to $1.6M from $3.9M at the end of 2025. The culprit? Accounts Receivable surged almost $10M (from $39.3M to $48.9M). The company is financing its franchisees' growth, which reduces liquidity despite high profitability.
Contradictory Headline Data
Despite management's optimism about recovery, a specific metric remains troubling: reported system-wide sales actually shrank from $125.9M to $117.8M YoY. While management correctly points to the MRI divestiture as the reason, the hard fact remains that the company's overall footprint and total transaction volume are smaller today than they were a year ago. Royalties are capped by absolute volume, not pro forma adjustments.
The Silent TrueBlue Elephant
In Q1, the massive narrative driver was a $105M all-cash unsolicited bid to acquire a segment of TrueBlue. In the Q2 release, there is absolutely zero mention of this deal, M&A pipeline, or deployment of their $41M credit facility. The sudden silence implies the acquisition likely failed, removing a major inorganic growth catalyst.
Other KPIs
Accelerating significantly from $3.3 million in the prior-year period. This represents an elite conversion rate, turning roughly 56% of total revenue into Adjusted EBITDA, showcasing the power of the high-margin royalty model.
Stable. The balance sheet remains heavily skewed toward equity ($68.8M). Notably, the company maintains zero drawn debt on its term loans, relying exclusively on its $41.0M line of credit availability for liquidity needs.
Guidance
Stable. Management declared their standard quarterly dividend of $0.06, matching prior quarters. With basic EPS jumping to $0.20 for the quarter, the payout ratio is a very safe 30%, leaving ample room for future increases or M&A deployment.
Key Questions
TrueBlue Acquisition Status
There was no mention of the $105 million unsolicited offer for TrueBlue's on-demand segment that dominated Q1 commentary. Is this deal officially dead, and if so, how does that shift your M&A focus?
Working Capital Runway
Accounts receivable grew by roughly $10 million over the last six months, draining cash to $1.6M. If system-wide sales continue to accelerate by 6-7%, will you need to tap the credit facility just to fund working capital?
National Accounts ROI
In Q1, you mentioned investments in the National Accounts program were yielding significant wins. How much of the 16.6% pro forma revenue growth in Q2 came specifically from these new national accounts versus legacy organic recovery?